CAS 2328073-61-4

N2-Cyclopropyl-N4-(1-isopropylpiperidin-4-yl)-6,7-dimethoxyquinazoline-2,4-diamine

CAS : 2328073-61-4

Formule : C₂₁H₃₁N₅O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 385.5031

Ref: IN-DA01KKFQ

N2-Cyclopropyl-N4-(1-Isopropylpiperidin-4-Yl)-6,7-Dimethoxyquinazoline-2,4-Diamine

CAS : 2328073-61-4

N2-Cyclopropyl-N4-(1-Isopropylpiperidin-4-Yl)-6,7-Dimethoxyquinazoline-2,4-Diamine

Degré de pureté : 98%

Masse moléculaire : 385.5g/mol

Ref: 54-OR1023192

ZT-12-037-01

CAS : 2328073-61-4

ZT-12-037-01

Degré de pureté : ≥98%

Masse moléculaire : 385.5g/mol

Ref: 54-BUP04849

ZT-12-037-01

CAS : 2328073-61-4

Zt-12-037-01 is a ATP competitive STK19 inhibitor（IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively).

Formule : C₂₁H₃₁N₅O₂

Degré de pureté : 99.56%

Couleur et forme : Solid

Masse moléculaire : 385.5

Ref: TM-T5597

ZT-12-037-01

CAS : 2328073-61-4

ZT-12-037-01 is a potential drug for the treatment of malignant melanoma. This drug is a phosphoramidate prodrug that is activated by an enzyme known as cytidine deaminase, which converts it to an active form of 5′-fluoro-5′-deoxycytidine. ZT-12-037-01 has been shown to inhibit the growth of malignant melanoma cells, and also induces cell death in these cells. ZT-12-037-01 also inhibits tumor progression in mice with preclinical models of cancer and research on this drug has helped advance our understanding of this disease.

Formule : C₂₁H₃₁N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 385.5 g/mol

Ref: 3D-DTD07361